In a rush? We’ve pulled together the top articles making headlines in the nursing and healthcare sectors this week, including a report revealing the high cost of undiagnosed rare diseases, a number of medicines getting close to EU approval, and GSK announcing their joint venture with Pfizer. Have a read!
Interested in Star’s innovative outsourcing and resourcing solutions?
Contact Head of Business Development, Ryan Wooller, at email@example.com, or get in touch on 07748 464 079.
On the hunt for a new role, or just curious?
Visit our candidate page, submit your CV to firstname.lastname@example.org, give our offices a ring, or sign up to our newsletter at the bottom of this page!
The NHS is set to offer mature students a £5,000 bonus to become mental health or learning disability nurses as part of a long-term plan to help boost the sector.
Patients with rare diseases have cost NHS England more than £3.4 billion in the last 10 years, analysis shows.
The European Medicines Agency’s human medicines committee (CHMP) has put forward seven medicines for approval in the region.
GSK has revealed it has entered into an agreement with US rival Pfizer to combine their consumer health businesses into one joint venture, expected to bring in sales of approximately £9.8bn.
Tens of thousands of low-skilled migrants could come to the UK to work for up to a year under proposed new post-Brexit immigration rules.
While you’re here…
…and are interested in our content, why not sign up to our newsletter? It’s just below here.